Prognostic Value of the Pretreatment Lung Immune Prognostic Index in Advanced Small Cell Lung Cancer Patients Treated With First-Line PD-1/PD-L1 Inhibitors Plus Chemotherapy

BACKGROUND: Lung immune prognostic index (LIPI) refers to a biomarker combining derived neutrophil-to-lymphocyte ratio (dNLR) and lactate dehydrogenase (LDH). Its prognostic effect on advanced small cell lung cancer (SCLC) patients receiving programmed cell death 1/programmed cell death ligand-1 (PD...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lingling, Pi, Chenghui, Yan, Xin, Lu, Jiangyue, Yang, Xuhui, Wang, Chunyu, Li, Xiaoyan, Zhang, Sujie, Zhang, Zhibo, Sun, Yi, Hu, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531596/
https://www.ncbi.nlm.nih.gov/pubmed/34692478
http://dx.doi.org/10.3389/fonc.2021.697865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531596/
https://www.ncbi.nlm.nih.gov/pubmed/34692478
http://dx.doi.org/10.3389/fonc.2021.697865

Ejemplares similares